Genetyka 360º

Proprietary Devices

Far far away, behind the word mountains, far from the countries Vokalia and Consonantia.

Microfluidic Cards

Far far away, behind the word mountains.

Primer Design

Far far away, behind the word mountains, far from the countries Vokalia and Consonantia

Data Analysis

Far far away, behind the word mountains, far from the countries Vokalia and Consonantia

AI-Powered
Support

Far far away, behind the word mountains.

Aktualności

2026.03.19

Genomtec plans to issue shares. The proceeds will be used to support the M&A process and commercialize projects. The company has concluded an investment agreement with a key shareholder.

2026.02.12

Genomtec lines up technology trials with potential Asian partners during M&A efforts

2025.07.31

Genomtec’s Supervisory Board appointed Leroy Huntley to the Company’s Management Board

Więcej aktualności

Genomtec in numbers

Number of Granted Patents

+35

Number of Patent Applications Filed

Years of Delivering Diagnostic Solutions

1st

Global leader in isothermal amplification solutions AI-powered

What makes us unique

We have created a broad IP portfolio enabling all aspects of our solutions

Proprietary AI approaches drive rapid assay design

We have developed, validated and published diagnostic test menu in all market segments

We have device and engineering capabilities
including scale up manufacturing

Exclusive team has significant technical and commercial exoerience

Poland is at the center of Europe,
cost effective and growing

Services & partnership areas

Implementing Genomtec technology in partner solutions and products2

Turnkey assay & hardware solutions

Isothermal Assay design & development

Genomtec Inside IP licenses for diagnostic technologies

AI data analysis & optimization process

Markets we serve

Life Sciences

$88B today
11.75% CAGR

Clinical Diagnostics

$86B today
6% CAGR

Food Safey

$25B today
7% CAGR

Veterinary

$8B today
9.75% CAGR

Pets

$3.6B today
9% CAGR

Bio Security

$5.5B today
13% CAGR

Awards

Maker in China

Genomtec took third place in the 2020.

Comeptition directly supported by the China-CEEC SME Research Institute Government Organisation, in which over 300 companies from Central and Eastern Europe and China compete. Genomtec ID is attracting the attention of Chinese investors, and the company is reassured that its efforts will be backed by the Chinese government’s anticipated expansion in that market at the local and central level.

China Shenzhen Innovation & Entrepreneurship

In November 2020 Genomtec took second place in the 4th edition.

Genomtec took second place in the 4th edition of the international competition and received an award of RMB 650,000 RMB, which is about PLN 400,000. Its innovative Genomtec ID platform beat out international competition with 1,046 projects entered. This win opens up new business and development opportunities on the Chinese market for the Company.

Next Health Investment Pitch

Genomtec took 1st place in May 2019.

Genomtec wins the competition organised for Polish companies who want to define economic reality through their innovations via Amgen and ImpactCEE. Amgen has been an international pioneer in biotechnology since 1980 and one of the world leaders in the production of biological medicines.

Start Up Med

Genomtec took 1st place in March 2019.

Genomtec won competition organised by the 4th Health Challenges Congress, a forum for a multi-topic discussion on key issues for healthcare systems in Europe.

Wszystkie nagrody